AmarKrishnaswamyMD
Cardiology • Cleveland, OHAdult Congenital Heart Disease, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Cardiac Critical Care
Assistant Professor, Medicine, Case Western Reserve Univ Sch of Med
Dr. Krishnaswamy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Desk J2-3
Cleveland, OH 44195Phone+1 716-983-2014
Education & Training
Cleveland Clinic FoundationFellowship, Interventional Cardiology, 2010 - 2012- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2006 - 2010
Johns Hopkins UniversityResidency, Internal Medicine, 2006
Yale School of MedicineClass of 2003
Certifications & Licensure
OH State Medical License 2006 - 2026
MD State Medical License 2007 - 2008- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) Start of enrollment: 2021 May 11
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 42 citationsOutcomes of patients with severe tricuspid regurgitation and congestive heart failure.Amer N. Kadri, Vivek Menon, Yasser Sammour, Rama Dilip Gajulapalli, Chandramohan Meenakshisundaram
Heart. 2019-12-01 - 16 citationsAdverse clinical outcomes in patients undergoing both PCI and TAVR: Analysis from a pooled multi-center registry.Arnav Kumar, Yasser Sammour, Shawn Reginauld, Kimi Sato, Nikhil Agrawal
Catheterization and Cardiovascular Interventions. 2021-02-15 - 94 citationsImpact of coronary artery disease on 30-day and 1-year mortality in patients undergoing transcatheter Aortic valve replacement: A meta-analysisKesavan Sankaramangalam, Kinjal Banerjee, Krishna Kandregula, Divyanshu Mohananey, Akhil Parashar
Journal of the American Heart Association. 2017-10-11
Journal Articles
- One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveBrian Whisenant, Samir R Kapadia, Mackram F Eleid, James M Mccabe, Amar Krishnaswamy, Richard W Smalling, Charanjit S Rihal, Raj R Makkar, JAMA Cardiology
- Focus on Transcatheter Aortic Valve Replacement Editorial Comment Optimizing Valve Sizing in Balloon-Expandable Transcatheter Aortic Valve Replacement∗Amar Krishnaswamy, Samir R Kapadia, ScienceDirect
- Original Investigation Editorial Comment Minimizing Stroke and Mortality Risks in Coronary Revascularization∗Amar Krishnaswamy, Samir R Kapadia, ScienceDirect
- Join now to see all
Authored Content
- One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveJuly 2020
- One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveJuly 2020
- The Utility of Rapid Atrial Pacing Immediately Post-TAVR to Predict the Need for Pacemaker ImplantationMay 2020
- The Utility of Rapid Atrial Pacing Immediately Post-TAVR to Predict the Need for Pacemaker ImplantationMay 2020
- Minimizing Stroke and Mortality Risks in Coronary RevascularizationJuly 2018
- Join now to see all
Press Mentions
TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients with Moderate ASOctober 28th, 2024- What to Expect Now That Transcatheter Tricuspid Valve Therapies Have Been ApprovedMay 13th, 2024
- Same-Day Discharge After TAVR Is Feasible and Safe, New Cleveland Clinic Study ConfirmsMarch 21st, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
